allcancercure.com

Researchers used a new imaging technique to take high quality color photographs of the clinical stages of ocular inflammation in mice, and the technology could help in the monitoring and treatment of diseases of the eye that may cause blindness.
The study, “The Clinical Time-Course of Experimental Autoimmune Uveoretinitis Using Topical Endoscopic Fundal Imaging with Histologic [...]

Early detection is critical to maintain healthy vision. With almost two-thirds of adult Americans, who do not wear corrective lenses, not receiving regular comprehensive eye exams, millions of people are putting their vision and their quality of life at risk, according to the American Optometric Association.
Glaucoma — often called “the sneak thief of sight” because [...]

Glaucoma is a stealthy illness; most people have no early symptoms and do not notice as their peripheral vision diminishes or blind spots occur. As a result, about half of the three million Americans with the disease are unaware of their condition. January is Glaucoma Awareness Month, and through the EyeSmart(TM) Campaign, the American Academy [...]

Schepens Eye Research Institute has named Congressman John P. Murtha, Chairman of the House Appropriations Subcommittee on Defense, this year’s Man of Vision for his advocacy on behalf of veterans blinded by war and for research to restore their vision.
Its highest honor, each year the Institute gives the Man of Vision Award to an individual [...]

About a year ago no doctor would believe that it was possible, but today it is becoming a mainstream procedure. Inpatient & Outpatient Clinics such as Hospitals, Emergency Rooms, Nursing & Elderly Homes, General & Specialty Practitioners are joining Ophthalmologists and Optometrists with “Provocative Test for Glaucoma”.
BiCOM Inc. and its unique, FDA approved Tonometer Diaton [...]

Pfizer Limited expresses concern that the latest NICE appraisal consultation document (ACD) regarding the use of treatments for wet Age-related Macular Degeneration (AMD), fails to provide any treatment choice for patients or physicians, by recommending only one anti-VEGF therapy for AMD.
NICE’s second ACD again fails to recommend Macugen(R) (pegaptanib) for patients affected by wet AMD [...]

Medecins Sans Frontieres on Saturday called on pharmaceutical company Roche to provide its oral antibiotic valganciclovir at a reduced cost in developing countries to help prevent a virus that can cause blindness among people living with HIV/AIDS, Reuters reports.
Cytomegalovirus retinitis — which can cause blindness within three to six months in people living with HIV/AIDS [...]

Genentech’s plan to limit the availability of cancer drug Avastin, which would require physicians to use a more expensive version of the drug called Lucentis to treat wet age-related macular degeneration, will cost taxpayers $1 billion to $3 billion annually, according to Sen. Herb Kohl (D-Wis.), Bloomberg/New York Times reports (Bloomberg/New York Times, 11/29). Genentech [...]

At a reception in the European Parliament last night, the Vision=E3 Partnership called for a more united approach to the training and employment of blind and partially sighted people in the workplace. The Parliamentary reception brought together MEPs, Commission officials and NGOs, who discussed best practices and a list of positive actions that Europe can [...]

A new online archive of more than 770 retinal topography maps covering 160 species has been launched by the Optometrists Association Australia.
Created by Professor Shaun P Collin from the School of Biomedical Sciences at the University of Queensland and launched in the industry journal Clinical and Experimental Optometry, the database is the first to bring [...]